Industry News

FDA Approves Pembrolizumab with Chemotherapy for Biliary Tract Cancer

On October 31, the US Food and Drug Administration (FDA) approved pembrolizumab to be used with gemcitabine and cisplatin for locally advanced unresectable or metastatic biliary tract cancer. 

For more information read the FDA announcement and Merck announcement

Posted 11/1/2023


1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
Email Us